English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Two validated chromatographic methods developed for the analysis of S clopidogrel bisulphate in the presence of its related substances listed in the United States and British Pharmacopoeias including its inactive R enantiomer are described. The first method is a simple thin layer chromatographic (TLC) method where separation is performed on pre-coated silica gel 60 F254 plates using methanol/diethylamine/heptanes/water containing 20 mg vancomycin hydrochloride (7 : 7 : 1.5 : 0.5 vol. %) as a mobile phase. R f  values were found to be 0.69, 0.74, 0.78, 0.84 and 0.88 for R clopidogrel, S clopidogrel, related substances A, B1 and B2, respectively. The second method depends on the separation by HPLC on a Lux polysaccharide chiral column with UV detection at 220 nm using 0.1 vol. % diethyl amine in methanol pumped at a rate of 1 mL min −1 . Retention times were found to be 1.90 min, 2.82 min, 3.00 min, 3.27 min and 3.71 min for the related substances A, B1, C which are clopidogrel R enantiomer, B2, and S clopidogrel, respectively. The proposed methods were validated in accordance with the ICH guidelines and successfully applied to the determination of S clopidogrel bisulphate in pure powder and dosage forms without interference from the excipients and to affirm the dosage form to be pure S clopidogrel and devoid of the R enantiomer, which is inactive.

Validated chiral chromatographic methods for clopidogrel bisulphate and its related substances in bulk drug and pharmaceutical dosage forms